Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy-Reference-Cited by-同舟云学术

Dosimetric predictors of toxicity and quality of life following prostate stereotactic ablative radiotherapy

Published:2020-03 Issue: Volume:144 Page:135-140
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Alayed Yasir,Davidson Melanie,Quon Harvey,Cheung Patrick,Chu William,Chung Hans T.,Vesprini Danny,Ong Aldrich,Chowdhury Amit,Liu Stanley K.^ORCID,Panjwani Dilip,Helou Joelle,Musunuru Hima B.,Pang Geordi,Korol Renee,Ravi Ananth^ORCID,McCurdy Boyd,Zhang Liying,Mamedov Alexandre,Deabreu Andrea,Commisso Angela,Commisso Kristina,D'Alimonte Laura,Ho Ling,Bhounr Zeeba,Loblaw Andrew^ORCID

Funder

Canadian Association of Radiation Oncology

Prostate Cancer Canada

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference17 articles.

1. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials;Viani;Int J Radiat Oncol,2009

2. Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomes;Zelefsky;Int J Radiat Oncol,2008

3. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials;King;Radiother Oncol,2013

4. Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer;Kishan;JAMA Netw Open,2019

5. Stereotactic body radiotherapy for low-risk prostate cancer: a ten-year analysis;Katz;Cureus,2017

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes;Advances in Radiation Oncology;2024-09

2. Risk factors for the long‐term persistent genitourinary toxicity after stereotactic body radiation therapy for localized prostate cancer: A single‐center, retrospective study of 306 patients;International Journal of Urology;2024-06

3. Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus;Nature Reviews Gastroenterology & Hepatology;2024-05-19

4. Predictive value of magnetic resonance imaging diffusion parameters using artificial intelligence in low-and intermediate-risk prostate cancer patients treated with stereotactic ablative radiotherapy: A pilot study;Radiography;2024-05

5. Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer;Radiotherapy and Oncology;2023-11